Given our findings, it is not unreasonable to speculate that aging when associated with inflammation/anemia and chronic disease settings may predispose these groups to more severe vascular disease because of the greater likelihood of elevated ACE2 expression linked to ongoing elevated hepcidin levels and particularly in pulmonary vascular beds. The gene discussed is ACE2; the disease is anemia.